BMC cancer · 2025
Evaluating the breast cancer quality of care indicators in Iran; multicenter study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rajabpour Mojtaba Vand, Seyyedsalehi Monireh Sadat, Nahvijou Azin, Nemati Saeed, Javanmard Shaghayegh Haghjooy, Manteghinejad Amirreza, Abdi Sepideh, Farazmand Borna, Pirnejad Habibollah, Sorkheh Arash Golpazir, Anasari Jamshid, Bahrami Masoud, Marzban Maryam, Ghoreishi Seyedeh Masoumeh, Nia Yahya Baharvand Iran, Bakhshi Fataneh, Ansari-Moghaddam Alireza, Binabaj Maryam Moradi, Nourmohammadi Hassan, Omranipour Ramesh, Abdollahi Alireza, Aghili Mahdi, Mohagheghi Mohammad Ali, Ghanbari-Motlagh Ali, Basu Partha, Boffetta Paolo, Zendehdel Kazem
Аннотация
BACKGROUND: Data on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.
METHOD: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.
RESULT: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.
CONCLUSION: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.
METHOD: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.
RESULT: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.
CONCLUSION: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.